Compare Riot Platforms Inc (RIOT) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Riot Platforms Inc vs TransMedics Group Inc — how do they compare? Riot Platforms Inc trades at $16.9 (market cap $6.32B), while TransMedics Group Inc trades at $78.15 (market cap $2.74B). The key difference: Riot Platforms Inc is far larger — about 2.3× TransMedics Group Inc's market cap, and Riot Platforms Inc is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Riot Platforms Inc for 16 Days and TransMedics Group Inc for 24 Days on average.
| RIOT | TMDX | |
|---|---|---|
Market Cap | $6.32B | $2.74B |
Volume | 30,571,756 | 949,331 |
Sector | Financials | Health |
52-Week High | $28.67 | $150.42 |
52-Week Low | $11.83 | $61.99 |
Typical Hold Time | 16 Days | 24 Days |
Enterprise Value | $6.73B | $3.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RIOT stock trades at $16.95, down 8.58% over 24 hours, reflecting bearish technical signals despite a bullish analyst consensus. The company reported a net loss of $663.18 million in 2025, with negative profit margins and cash flow, but is pivoting to AI data center leasing with $9.8 billion in contracted revenue through 2048, per Seeking Alpha on 2026-10-01.
The outlook hinges on execution of the AI strategy, offering significant upside to the $31.64 consensus price target, but high execution risk and persistent losses pose threats to near-term shareholder value amid volatile market conditions.
TransMedics Group (TMDX) trades at $78.17, down 3.58% on the day, with a bearish technical signal and mixed earnings history. The company reported strong 2025 results with $605.49M revenue and $190.29M net income, but 2026 projections show margin compression. Recent news highlights insider buying and leadership changes alongside legal investigations into fiduciary duties, creating a complex sentiment backdrop.
The stock offers growth potential with a consensus price target of $99.75, but faces risks from earnings misses, margin pressure, and ongoing legal scrutiny. Analyst consensus remains bullish with 69% buy ratings, yet investors must weigh robust profitability metrics against execution and regulatory uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Riot Platforms Inc
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
